BOE-A-2026-5206 ·5 March 2026 ·Resolution Low impact
Tax

Marmelant, SL: €140,400 fine for serious and very serious cosmetic manufacturing breaches

The Spanish Agency of Medicines and Medical Devices has imposed a €140,400 fine on Marmelant, SL, following the final administrative resolution (art. 114.4 TRLGUM). The penalty stems from a serious infringement for manufacturing or importing cosmetic products without the mandatory responsible declaration (art. 113.2 b) 13.ª TRLGUM) and a very serious infringement for producing products under deficient technical and sanitary conditions that compromise safety (art. 113.2 c) 6.ª TRLGUM).

In 2 key points

  1. €140,400 fine for a serious infringement (art. 113.2 b) 13.ª TRLGUM) (art. 113.2 b) 13.ª)
  2. Very serious infringement due to deficient technical and sanitary conditions affecting safety (art. 113.2 c) 6.ª TRLGUM) (art. 113.2 c) 6.ª)

How it affects those involved

For the sanctioned company, Marmelant, SL, this represents a financial burden of €140,400 and the public disclosure of its liability for failing to meet safety requirements and responsible declaration obligations (art. 114.4 TRLGUM). For the cosmetics sector, the resolution reinforces oversight regarding compliance with technical and sanitary conditions and the mandatory nature of the responsible declaration for manufacturing or importing products.

Lifecycle

2026-03-05PublishedPublished in the BOE
Official text Based on BOE data (boe.es). Information, not advice.
PDF on boe.es

Does this provision affect you?

The tax team reviews your specific situation.

Talk to the tax team
This analysis is informational only and does not constitute legal advice or create a client-adviser relationship. BM Consulting.
Email
Contact